GV (nerve agent): Difference between revisions
Appearance
Content deleted Content added
m Bot: link to Commons:Category:GV nerve agent |
|||
Line 44: | Line 44: | ||
[[Category:Amines]] |
[[Category:Amines]] |
||
[[Category: |
[[Category:Phosphorofluoridates]] |
||
[[Category:Anticholinesterases]] |
[[Category:Anticholinesterases]] |
||
[[Category:Nerve agents]] |
[[Category:Nerve agents]] |
Revision as of 18:29, 13 February 2011
Names | |
---|---|
IUPAC name
2-(dimethylamino-fluorophosphoryl)oxy-N,N-dimethylethanamine
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C6H16FN2O2P | |
Molar mass | 198.176 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
GV (O-[2-(dimethylamino)ethyl]-N,N-dimethylphosphoramidic fluoride) is an organophosphate nerve agent. GV is a part of a new series of nerve agents with properties similar to both the "G-series" and "V-series". It is a potent acetylcholinesterase inhibitor with properties similar to other nerve agents, being a highly poisonous vapour. Treatment for poisoning with GV involves drugs such as atropine, benactyzine, obidoxime and HI-6.[1][2]
References
- ^ Fusek J, Bajgar J. Treatment of intoxication with GV compound in laboratory rats. Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity v Hradci Kralove. 1994;37(2):57-62. PMID 7784799
- ^ Kassa J, Bajgar J. Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice. Acta Medica (Hradec Kralove). 1996;39(1):27-30. PMID 9106387
External links
Wikimedia Commons has media related to GV nerve agent.